XBI Biotech sector
Company Analysis
Latest News
Biotech Stocks Tumble Amid Broader Tech and Growth Sell-Off
The biotechnology sector, as measured by the XBI ETF, dropped significantly during the current market session, caught in a wider market downturn affecting...
🔴 XBI is trading 3.67% down today as S&P 500 and Nasdaq fall
XBI is trading at $153.75, down 3.67%, alongside declines across the broader market. - The S&P 500 is down 1.49%, while the Nasdaq is down 2.94%. - No clear...
Biotech Sector Surges on Reduced Regulatory Concerns Post-Midterm Elections
The biotechnology sector, proxied by the XBI ETF, experienced a significant rally following the Democratic sweep in the midterm elections. Wall Street analysts...
Biotech Sector Rallies on Strong Amgen Earnings and Positive Industry Outlook
The biotechnology sector is trading higher in the pre-market, driven by strong quarterly results and increased full-year guidance from industry heavyweight...
Biotech Sector Surges on Broad Market Rotation and Positive News Flow
The biotech sector, as measured by the XBI ETF, rallied sharply in the pre-market session, driven by a broader market rotation out of large-cap technology...
🟢 XBI is trading 3.14% up today on biotech dealmaking and clinical progress
XBI is trading 3.14% up today at $152.50, with the move appearing tied to biotech-sector strength rather than an ETF-specific catalyst. - Merck KGaA’s...
Biotech Sector Surges on M&A Activity and Positive Clinical Trial Data
The biotechnology sector is experiencing a significant rally, with the XBI ETF up over 2%. This move is largely driven by strong M&A activity, highlighted by...
Biotech Sector Rallies on M&A Activity and Anticipation of Key Cancer Data
The biotech sector moved higher, fueled by news that Germany's Merck KGaA will acquire U.K.-based Silence Therapeutics for $1.3 billion, representing a...
Biotech Stocks Fall on Broad Market Weakness and Tech Sell-off
The biotech sector, as measured by the XBI ETF, experienced a significant pre-market decline of -3.65% amid a broader market downturn. [11] This was largely...
🔴 XBI is trading 3.26% down today amid biotech-sector weakness
XBI is trading at $144.89, down 3.26%, amid weakness across biotech. - A sector update cited rotation away from higher-growth investments during the regular...
Biotech Sector Rallies on Positive Clinical Data and Regulatory News
The biotechnology sector, as measured by the XBI ETF, is trading higher today driven by a series of positive company-specific news announcements. Notably,...
🔴 XBI is trading 3.06% down amid a biotech-sector pullback
XBI is trading -3.06% at $146.76 on October 13, 2026, amid a biotech-sector pullback, though coverage identifies no clear single catalyst. - Momentum names are...
🟢 XBI is trading 3.07% up today as biotech IPOs raised $161.7 million
XBI is trading 3.07% up at $153.87, aligned with a broader biotech-sector rally. - Lilly-backed TRex Bio and Retension Pharmaceuticals raised about $161.7...
Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
The biotech sector is experiencing a significant rally, with the XBI ETF up 2.50%, driven by strong investor sentiment following a pair of successful Initial...
Biotech Sector Declines Without Clear Catalyst
The biotech sector, as measured by the XBI ETF, is down more than 2% in the current session, continuing a recent trend of weakness. There is no single,...
🔴 XBI is trading 3.17% down today amid broad biotech-sector pressure
XBI is trading 3.17% down now at $151.24, with broad-based negative sentiment across biotechnology weighing on the sector. - The sector update cites increased...
Biotech Sector Declines on Broad-Based Negative Sentiment
The biotechnology sector, as measured by the XBI ETF, traded down 2.50% in the current session amid a generally negative sentiment for the industry. No single,...
Biotech Sector Declines on Negative Company-Specific News
The biotech sector, as measured by the XBI ETF, traded lower in the pre-market session following disappointing news from several companies. Eli Lilly announced...
🔴 XBI is trading 3.27% down today as broad risk-off trading pressures biotech valuations
XBI is trading 3.27% down at $156.58, with broad risk-off trading weighing on biotech valuations. - The Nasdaq is down 1.00%, while rising crude oil and the...
Biotech Sector Surges in Pre-Market on Multiple Positive News Snippets
The biotechnology sector, as measured by the XBI ETF, is trading significantly higher in the pre-market session. This move appears to be driven by a collection...